Autor: |
Spring MD; Department of Bacterial and Parasitic Diseases, US Army Medical Directorate of the Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.; The Henry M. Jackson Foundation for the Advancement of Military Medicine., Sousa JC; Experimental Therapeutics Branch., Li Q; Experimental Therapeutics Branch., Darko CA; General Dynamics Information Technology, Silver Spring., Morrison MN; Clinical Trials Center., Marcsisin SR; Food and Drug Administration, Boston, Massachusetts., Mills KT; Davita Medical Group, Colorado Springs, Colorado., Potter BM; Experimental Therapeutics Branch., Paolino KM; Division of Infectious Disease, SUNY Upstate Medical University, Syracuse, New York., Twomey PS; Licensing and Early Development-Oncology, Genentech, South San Francisco, California., Moon JE; Malaria Vaccine Branch., Tosh DM; Clinical Operations, Government and Public Health Solutions, ICON, Hinckley, Ohio., Cicatelli SB; Clinical Trials Center., Froude JW; Vaccines/Therapeutics Division, Defense Threat Reduction Agency, Fort Belvoir, Virginia., Pybus BS; Experimental Therapeutics Branch., Oliver TG; Clinical Pharamacology Division, Uniformed Services University of the Health Sciences., Mccarthy WF; U. S. Army Medical Materiel Development Activity, Fort Detrick, Maryland., Waters NC; Department of Bacterial and Parasitic Diseases, US Army Medical Directorate of the Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand., Smith PL; Center for Enabling Capabilities., Reichard GA; Experimental Therapeutics Branch., Bennett JW; Infectious Diseases Division, Department of Medicine, Uniformed Services University of the Health Sciences.; Bacterial Diseases Branch, Walter Reed Army Institute of Research. |